A detailed history of Arlington Financial Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Arlington Financial Advisors, LLC holds 46,041 shares of GILD stock, worth $4.06 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
46,041
Previous 44,801 2.77%
Holding current value
$4.06 Million
Previous $3.28 Million 3.75%
% of portfolio
0.86%
Previous 0.89%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$63.15 - $72.88 $78,306 - $90,371
1,240 Added 2.77%
46,041 $3.16 Million
Q1 2024

Apr 17, 2024

BUY
$71.58 - $87.29 $120,111 - $146,472
1,678 Added 3.89%
44,801 $3.28 Million
Q4 2023

Jan 08, 2024

BUY
$73.27 - $83.09 $2,857 - $3,240
39 Added 0.09%
43,123 $3.49 Million
Q3 2023

Nov 02, 2023

BUY
$73.94 - $80.67 $25,213 - $27,508
341 Added 0.8%
43,084 $3.23 Million
Q2 2023

Jul 24, 2023

BUY
$76.01 - $86.7 $152 - $173
2 Added 0.0%
42,743 $3.29 Million
Q1 2023

May 05, 2023

SELL
$77.31 - $88.08 $498,031 - $567,411
-6,442 Reduced 13.1%
42,741 $3.55 Million
Q4 2022

Jan 18, 2023

SELL
$62.32 - $89.47 $10,656 - $15,299
-171 Reduced 0.35%
49,183 $0
Q3 2022

Oct 18, 2022

SELL
$59.54 - $68.01 $206,246 - $235,586
-3,464 Reduced 6.56%
49,354 $3.05 Million
Q2 2022

Jul 13, 2022

BUY
$57.72 - $65.01 $72,438 - $81,587
1,255 Added 2.43%
52,818 $3.27 Million
Q1 2022

Apr 26, 2022

BUY
$57.92 - $72.58 $8,572 - $10,741
148 Added 0.29%
51,563 $3.07 Million
Q4 2021

Jan 18, 2022

BUY
$64.88 - $73.64 $38,084 - $43,226
587 Added 1.15%
51,415 $3.73 Million
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $13,605 - $14,679
201 Added 0.4%
50,828 $3.55 Million
Q2 2021

Jul 30, 2021

BUY
$63.47 - $69.35 $1.06 Million - $1.16 Million
16,700 Added 49.22%
50,627 $3.49 Million
Q1 2021

Apr 23, 2021

BUY
$60.0 - $68.46 $1.59 Million - $1.81 Million
26,438 Added 353.02%
33,927 $2.19 Million
Q4 2020

Jan 29, 2021

SELL
$56.65 - $64.55 $1.58 Million - $1.8 Million
-27,922 Reduced 78.85%
7,489 $436,000
Q3 2020

Nov 03, 2020

BUY
$62.1 - $78.08 $14,220 - $17,880
229 Added 0.65%
35,411 $2.24 Million
Q2 2020

Jul 15, 2020

BUY
$72.34 - $84.0 $66,335 - $77,028
917 Added 2.68%
35,182 $2.71 Million
Q1 2020

Apr 09, 2020

BUY
$62.63 - $80.22 $479,620 - $614,324
7,658 Added 28.78%
34,265 $2.56 Million
Q4 2019

Jan 15, 2020

SELL
$61.62 - $67.78 $753,735 - $829,084
-12,232 Reduced 31.49%
26,607 $1.73 Million
Q3 2019

Nov 08, 2019

BUY
$62.51 - $69.0 $56,634 - $62,514
906 Added 2.39%
38,839 $2.46 Million
Q2 2019

Aug 05, 2019

BUY
$61.87 - $69.38 $52,836 - $59,250
854 Added 2.3%
37,933 $2.56 Million
Q1 2019

May 13, 2019

BUY
$62.53 - $70.05 $235,925 - $264,298
3,773 Added 11.33%
37,079 $2.41 Million
Q4 2018

Jan 17, 2019

SELL
$60.54 - $79.0 $45,586 - $59,487
-753 Reduced 2.21%
33,306 $2.08 Million
Q3 2018

Nov 14, 2018

BUY
$71.28 - $78.92 $12,402 - $13,732
174 Added 0.51%
34,059 $2.42 Million
Q2 2018

Aug 13, 2018

BUY
$64.88 - $75.68 $473,234 - $552,009
7,294 Added 27.43%
33,885 $2.64 Million
Q1 2018

Apr 20, 2018

BUY
$72.84 - $88.8 $32,049 - $39,072
440 Added 1.68%
26,591 $1.98 Million
Q4 2017

Feb 01, 2018

BUY
$71.15 - $83.52 $1.86 Million - $2.18 Million
26,151
26,151 $2.13 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Arlington Financial Advisors, LLC Portfolio

Follow Arlington Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Financial Advisors, LLC with notifications on news.